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Abstract
Background: Many aging changes seem similar to those elicited by sleep-deprivation and psychosocial stress. Further, sleep
architecture changes with age suggest an age-related loss of sleep. Here, we hypothesized that sleep deprivation in young
subjects would elicit both stress and aging-like transcriptional responses.
Methodology/Principal Findings: F344 rats were divided into control and sleep deprivation groups. Body weight, adrenal
weight, corticosterone level and hippocampal CA1 transcriptional profiles were measured. A second group of animals was
exposed to novel environment stress (NES), and their hippocampal transcriptional profiles measured. A third cohort
exposed to control or SD was used to validate transcriptional results with Western blots. Microarray results were statistically
contrasted with prior transcriptional studies. Microarray results pointed to sleep pressure signaling and macromolecular
synthesis disruptions in the hippocampal CA1 region. Animals exposed to NES recapitulated nearly one third of the SD
transcriptional profile. However, the SD -aging relationship was more complex. Compared to aging, SD profiles influenced a
significant subset of genes. mRNA associated with neurogenesis and energy pathways showed agreement between aging
and SD, while immune, glial, and macromolecular synthesis pathways showed SD profiles that opposed those seen in aging.
Conclusions/Significance: We conclude that although NES and SD exert similar transcriptional changes, selective
presynaptic release machinery and Homer1 expression changes are seen in SD. Among other changes, the marked decrease
in Homer1 expression with age may represent an important divergence between young and aged brain response to SD.
Based on this, it seems reasonable to conclude that therapeutic strategies designed to promote sleep in young subjects
may have off-target effects in the aged. Finally, this work identifies presynaptic vesicular release and intercellular adhesion
molecular signatures as novel therapeutic targets to counter effects of SD in young subjects.
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Introduction
Age-related cognitive deficits are highly prevalent and
constitute an important health risk in the human population
(reviewed in [1]). They can presage development of neurode-
generative disease [2,3,4], and are a primary reason for elderly
placement in assisted living facilities [5]. Perturbations in sleep
are also a common complaint among the elderly and include
circadian advance, sleep fragmentation, and insomnia
[6,7,8,9,10,11]. Healthy young adults show some aging-like
phenotypes when deprived of sleep, including daytime sleepiness
[12], metabolic syndrome-like changes, and cognitive deficits
[13,14,15]. This is consistent with work suggesting that sleep
promotes memory [16,17,18,19], possibly through slow wave
influence on synapses [20,21,22] and/or promotion of macro-
molecule synthesis [23]. Further, numerous studies have pointed
to the deleterious effects of stress and stress hormones on brain
function and a major hypothesis of aging (the glucocorticoid
hypothesis) posits that continued exposure to stress and stress
hormones over age is a fundamental cause of age-related deficits
in various systems (reviewed in [24,25,26]). Thus, dysregulated
sleep and stress seen with age might contribute to age-related
functional changes. Despite the seemingly similar effects of age,
stress and sleep deprivation (SD), and the high prevalence of
sleep changes and new onset stress with age, relatively few studies
have tested for a molecular relationship between the influences of
SD, stress, and aging on brain tissue.
Here, we hypothesized that an aged or stressed animal’s
hippocampal transcriptional profile would be similar to that of a
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sleep-deprived subject. We tested a prediction of this hypothesis
by sleep depriving young animals and statistically testing for
aging- or stress-like transcriptional phenotypes in the hippocam-
pus. Young F344 rats were sleep deprived for 24 or 72 hours
using the modified multi-platform ‘flower pot’ method [27,28].
Blood corticosterone levels, adrenal weights, body weights, and
hippocampal CA1 gene expression profiles were measured. A
second set of rats was exposed to novel environment stress for 24
or 72 hours to help control for non-specific stress effects of the
environmental change necessitated by the sleep deprivation
protocol. In a third set of animals, the SD protocol was applied
and gene products were validated at the protein level using
Western blots. Data were subjected to bioinformatic analysis and
contrasted with results from prior transcriptional profiling studies
as noted in Results.
Transcriptional comparison suggests SD, stress and aging
interact with a similar subset of genes within the hippocampal
transcriptome. However, although there was strong directional
agreement between SD and NES, notable disagreements between
SD and aging were seen, including opposite inflammatory and
glial expression changes. Our studies also identified SD-specific
genes and gene profiles that may represent targets for therapeutic
intervention. These include the previously identified Homer1 as a
potential sleep regulation molecule, but also other novel candidate
genes involved in pathways related to synaptic function, vesicular
release and intercellular adhesion. However, because of the more
complex relationship between SD and aging, it is also likely that
sleep or stress-related interventions designed for younger subjects
may have off-target effects in aged subjects.
Materials and Methods
Ethics
Use of vertebrate animals was carried out in strict accordance
with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol (# 2008-0347) was approved by the University of
Kentucky Office of Research Integrity Institutional Animal Care
and Use Committee. Euthanatising (CO2) anesthesia was used
and all efforts were made to minimize suffering.
Subjects
Male Fischer 344 rats (3–5 months old, Harlan, Indianapolis)
were housed 2 per cage and maintained on a 12:12 light/dark
cycle in the housing facility with ad libitum food and water.
Subjects were acclimated to the housing facility for two weeks
prior to initiating the study. All procedures involving animals
adhered to the NIH Guide for the Care and Use of Laboratory
Animals and were approved by the Animal Care and Use
Committee at the University of Kentucky. 110 animals were
used, 38 in cohort 1 (one animal was not included because of
poor health), 32 in cohort 2, and 40 in cohort 3. Subjects in
cohorts 1 and 2 were used for microarray analysis and were
assigned to one of 5 treatment groups: Home Cage (HC) n = 17;
24 hour sleep deprivation (24SD) n = 16; 72 hour sleep
deprivation (72SD) n = 20; 24 hour novel environment stress
(24NES) n = 10; 72 hour novel environment stress (72NES) n
= 6. SD and HC animals in cohort 1 were trained on the one-
way active avoidance task prior to SD. No effect of training was
noted in stress or microarray measures (not shown). Cohorts 1
and 2 were combined for microarray analyses. Animals in the
third cohort were used for protein measures and included HC n
= 16; 24SD n = 12; and 72SD n = 12.
Sleep Deprivation
The multiple platform modification [29] of the classic ‘flower
pot’ [28] technique in which animals are placed on an elevated
platform over water was used. Based on prior research regarding
the stress-reducing action of pairing socially familiar animals [27],
long-standing cage mates were housed together in sleep depriva-
tion chambers. Pairs of SD animals (cage mates) were p laced in
large 39x29x29 water tight polycarbonate chambers covered with
stainless steel grating (Braintree Scientific, Braintree, MA). The
chamber was filled with water to a depth of 2 inches. Twenty four
inverted clay flower pots served as elevated platforms (4 inch
diameter) within each chamber, allowing the animals to stay dry,
move around, and access food and water supplied through the
grated chamber lid.
Novel Environment Stress (NES)
Procedures for reducing/preventing sleep are often stressful, as
those for inducing stress can be sleep-depriving [30]. To help
address this, for a subset of animals, the sleep depriving
component was prevented by placing a rubberized metal grid
over the platforms. Thus, NES animals were exposed to the same
novel environment as the SD animals, but were not constrained
from sleeping. These NES animals paralleled the sleep deprivation
exposure duration (24 hour- n = 10, and 72 hour- n = 6) and
hippocampal microarray signatures also were collected.
Tissue Isolation
On the day that animals were removed from the SD chambers,
they were deeply anesthetized with CO2 gas and decapitated.
Trunk blood was collected, immediately centrifuged to isolate
serum, and aliquots were frozen (-80 C) until further use.
Corticosterone (CORT) radioimmunoassay (RIA) was used to
measure CORT levels (RIA kit, ICN Biomedicals, Costa Mesa,
CA) according to manufacturer’s directions. Briefly, 10 ul of serum
was diluted 1:200 in abac buffer and incubated in antibody for 2
hours at room temperature. All samples were run in duplicate and
averaged.
Brains were removed and immediately placed in oxygenated
artificial cerebrospinal fluid (aCSF) containing (in mM) 114NaCl,
2.5 KCl, 2MgCl2, 30 NaHCO3, 10 Glucose and 2.2CaCl2.
Hippocampi were dissected as described previously [31,32].
Briefly, hippocampi immersed in 0uC oxygenated aCSF were
placed on a chilled glass petri dish, and the CA1 region dissected
away from dentate gyrus, CA3 and entorhinal cortex along the
long axis of the hippocampus. CA1 tissue was flash frozen and
stored at -80uC until further use.
RNA Extraction
RNA was extracted from each CA1 tissue block, as described
previously [31,32,33] using TRIzol (Invitrogen) followed by
ethanol precipitation, and was reconstituted in RNase-free water.
For each sample, 20 mg of biotin-labeled cRNA was generated
from 5 mg of total RNA according to manufacturer’s instructions
(Affymetrix). 20 mg biotin-labeled cRNA was applied to a rat
RGU34A GeneChip (Affymetrix) for hybridization (one chip per
animal).
Microarray Protocol
The Affymetrix Gene Chip Operating Software (GCOS) quality
control algorithm showed no significant difference (p.0.2, 1-
ANOVA) for three quality control measures: scaling factor (2.45+/
20.06, target intensity of 500); GAPDH 39:59 (1.0460.01); and b
actin 39:59 (1.3160.02). There was no significant difference among
Transcriptional Profile of Sleep Deprivation
PLoS ONE | www.plosone.org 2 July 2012 | Volume 7 | Issue 7 | e40128
treatment groups regarding percent of probe sets rated present
(39.560.03% present); p.0.4, 1-ANOVA). However, GCOS
measures of background signal (74.962.1 cohort 1; 59.862.3
cohort 2) and RawQ (2.360.1 cohort 1; 1.960.1 cohort 2), as well
as a chip x chip correlation matrix of signal intensity data (not
shown), pointed to a global decrease in background signal intensity
in Cohort 2. To control for this, each gene’s expression values for
HC, 24SD and 72SD was standardized separately within cohort 1
and cohort 2, and then the two cohorts were combined. This
retained the variability of each cohort, but removed the ‘cohort
effect’ from the data. The raw signal intensity values (MAS5) and
scanned images (.cel files) have been deposited to the MIAME
compliant Gene Expression Omnibus (GEO) database ([34] -
accession #GSE34424).
Values were transferred to Excel (2007, Microsoft), Bioconduc-
tor [35], or MultiExperiment Viewer (MEV, [36]), and integrated
with annotation data (Affymetrix, June 2011). Pre-statistical
filtering retained ‘A’ grade probe sets that were uniquely
annotated with gene symbols and had at least 6 presence calls
across all 69 HC and SD chips. This criterion was selected based
on factorial analysis demonstrating ,5% probability of 6 or more
chips being rated present for a given probe set by chance (Blalock,
unpublished observations).
Biological Pathway Identification
Functional processes significantly overrepresented in the data
set were determined using the Database for Annotation, Visual-
ization and Integrated Discovery (DAVID) overrepresentation tool
[37] on the Gene Ontology (GO) database [38]. The ‘table
clustering’ option and streamlined ‘GO-FAT’ subset of the GO
were used for analysis. A single illustrative process from each
cluster (p,0.05; kappa statistic/‘EASE score’) [39], populated by
between 3 and 50 genes, is reported in Results.
Overlap Analysis
For comparisons across different transcriptional profiles (e.g,
sleep deprivation vs. aging, or sleep deprivation vs. novel
environment stress), statistical similarity is determined by ‘overlap
analysis’ as previously reported [40,41,42,43,44,45]. Briefly, a total
number of genes available for testing across two studies (common
background) is established based on gene symbol level annotation
and high quality signal in both studies. Among this set of
background, the number genes significant in both studies (the
‘overlap’) is statistically contrasted with the number of genes one
would expect in the overlap by chance using the binomial test [46].
Western Blot Experiments
A separate cohort of animals was exposed to the SD paradigm
(n = 12–16/group; HC, 24SD and 72SD), and their hippocampi
removed for protein extraction and Western blot analysis. Briefly,
intact hippocampi were flash-frozen in liquid nitrogen and stored
at -80uC until use. Hippocampi were homogenized in 500 ml
0.3 M sucrose buffer containing protease inhibitors (300 mM
sucrose, 75 mM NaCl, 10 mM Tris pH 7.4, 20 mM EDTA,
20 mM EGTA, 1 mg/ml pestatin A, 10 mg/ml leupeptin, 20 mg/
ml, 200 nM PMSF, 8 mg/ml calpain inhibitor I & II). Tissue was
centrifuged in a microfuge (3500 rpm/1000 g65 min) to remove
cellular debris. Supernatant (membrane/cytosol fraction) was
collected and stored at -80uC until further use.
Protein concentration was determined by the Lowry method
with no significant difference among treatment groups
(35.261.2 mg/ml; p = 0.76; 1-way ANOVA). For each sample,
200 mg of protein was loaded on Bio-Rad gradient gels (4–20%).
Proteins were resolved by electrophoresis and transferred to
nitrocellulose membranes for quantitative Western blot as
described previously [47]. Membranes were incubated at 4uC
overnight in I-Bloc (Tropix) along with primary antibodies, which
included: Agrin (1:000 dilution, Chemicon catalogue MAB5204,
monoclonal); Adrb2 (1:5000, Chemicon catalogue AB5617,
polyclonal); Sgk-1 (1:1000, Upstate catalogue # 07-315, polyclon-
al); Nr3b (1:2500, Upstate catalogue # 07-351, polyclonal),
Neurexin 1 (1:1000, Biovision catalogue # 3428-100, polyclonal);
EAAC1 (1:500, Upstate catalogue # MAB1587, monoclonal); and
GluR2/3 (1:5000, Upstate catalogue # 07-5998, polyclonal).
Primary antibodies were detected using the appropriate HRP-
conjugated secondary antibody, diluted in I-Bloc at 1:10,000, and
detected using the ECL-plus Western kit (GE Healthcare). Protein
levels were quantified using a Storm 860 PhosphoImager
(MolecularProbes).
Other Microarray Studies
Published microarray studies of aging rat hippocampus, along
with their Gene Expression Omnibus data deposition references
include: GSE854 [31]; GSE5666 [33]; GSE9990 [32]. Procedures
for statistical comparison of the present work to these published
studies are similar to those published previously [40,45,48] except
as noted in Results.
Statistical Analysis
All statistical analyses were performed using SigmaStat, SAS,
and/or custom formulae in Excel (Microsoft, 2007). Outlier values
(.2SD of treatment mean) were treated as missing values. For
microarray data, the error of multiple testing for genes rated
significant (1-ANOVA, p#0.05) was estimated by the False
Discovery Rate (FDR) procedure [49], with median FDR
reported. Significant genes were further investigated with a post-
hoc template matching strategy [32,45].
Interpretation Caveats
The following are important considerations/limitations regard-
ing the interpretation of this data. First, mRNA and protein levels
are used to infer functional changes, but are not direct measures of
function. Second, gene products are pleiotropic and can play
different roles depending on the cell/tissue type and temporal
context of their expression. Third, although enriched in neurons,
the CA1 region of the hippocampus is not exclusively neuronal.
Astrocytic, oligodendrocytic (richly myelinated perforant path and
alveus), microglial and vascular cells/tissue are transcriptional
contributors. Fourth, the SD profile can differ across brain regions
[50] and, probably, species. To help guard against mis- (or over-)
interpretation, particular attention is paid to genes that participate
in larger, statistically significant functional groups, are known to be
expressed in brain tissue, and/or have been found to change in
prior studies examining similar phenomena in similar tissue.
Results
Stress-related Measures
We measured three stress-related outcome variables: body
weight, adrenal size, and corticosterone level in control and SD
animals. Although not a large effect (,5%), there was a consistent
and significant weight loss associated with sleep deprivation
(Fig. 1A). Adrenal weights were not significantly increased in SD
animals (Fig. 1B). CORT levels (Fig. 1C) were measured at the
circadian nadir. 24SD but not 72SD subjects showed a significant
elevation. Control CORT levels are in range with those reported
in other studies [51,52].
Transcriptional Profile of Sleep Deprivation
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Gene expression Patterns
The CA1 hippocampal subregion (Methods) was used for gene
expression microarray analysis. Data were filtered (Fig. 1D) to
remove probe sets that were poorly annotated, redundant, or had
weak expression levels. One-way ANOVA identified nearly 700
genes significantly influenced by SD. Approximately 8.4% of those
are likely to be present due to the error of multiple testing as
estimated by the False Discovery Rate (FDR) procedure. We
consider this a fairly strong result, particularly compared to studies
on normal aging, where FDRs are typically in the 20-25% range.
However, the present work also has a higher n per treatment
group, likely increasing statistical power.
The combination of significance and direction of change for
significant genes constitutes the gene expression pattern for a
single gene. Here, we used template matching [32] to parse
ANOVA-significant genes into expression patterns. Four experi-
menter-defined expression patterns (templates) were constructed to
examine SD effects: sustained, transient, delayed, and linear (Fig. 2
A, B, C, D). Treatment group mean gene expression for every
significant gene was correlated with each of these four templates,
and each gene was assigned to the template with which it most
strongly correlated. Positive correlations were interpreted as
‘‘increased’’ with sleep deprivation, and negative correlations as
‘‘decreased’’. The complete list of all significant genes, along with
their template assignments, mean expression values and 1-way
ANOVA p-values, are provided in Table S1.
Heat maps (Fig. 2, center) show color-coded standardized
expression values for 10 representative genes from each pattern for
each subject. On the right, the averaged expression values for all
significant genes assigned to each template are shown, along with
the total number of genes assigned to that template. Interestingly,
most significant genes were assigned to either the sustained or
transient templates. Further, the 72SD group tended to show a
lesser (albeit non-significant) tendency to recover back to HC
values.
To determine whether the number of genes categorized into
each expression pattern was significant, we ran a Monte Carlo
simulation. For the simulation, the data table used the same
number of chips (columns), and same number of genes (rows), and
the same ANOVA and post-hoc template matching strategy as the
original microarray data set. However, all signal intensity values
were replaced with randomly generated numbers. Then the
number of significant ‘‘genes’’ that were categorized in each
template was counted. This process was repeated 1000 times, with
new randomly generated numbers each time. Out of these 1000
iterations, on average, the random data identified an average of 14
Figure 1. Sleep deprivation reduces body weight, increases corticosterone, and causes detectable changes in hippocampal gene
expression. A. Body weight was significantly reduced in all SD animals from both cohorts. Weights measured at the end of the study are expressed
as a percentage of the body weight measured at the beginning of the study, a 4 day span (1-way ANOVA [* F2, 49 = 29.1, p = 4.8610
29]). B. Adrenal
weights measured from animals in cohort 1(HC n = 9; 24SD n = 9; 72SD n = 10) were not significantly increased (p = 0.22). C. Corticosterone levels
from animals in cohort 2 (HC n = 12; 24SD n = 9; 72SD n = 13) were significantly increased at 24SD (1-way ANOVA [F2,31 = 5.93, p = 0.0066]; *post-hoc
Tukeys). D. Of 8799 total probe sets, 2167 were rated present and had unique gene symbol level annotations. These were tested by 1-way ANOVA
across HC, 24SD, and 72SD groups. A total of 679 genes were rated significant (p#0.05). The False discovery rate (FDR) procedure estimates that 8.4%
of these results are significant due to the error of multiple testing.
doi:10.1371/journal.pone.0040128.g001
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‘genes’ in the sustained and delayed templates, 19 ‘genes’ in the
transient template, and 9 ‘genes’ in the linear template. These
results indicate that different templates have different random
probabilities of having genes assigned to them, and this should be
taken into account during this type of analysis. However, the
actual data for all templates (Fig. 2, right) far exceed these Monte
Carlo estimated values (p#1.361028 for all templates, binomial
test). Thus, all template-identified genes are occurring at a
significantly greater frequency than expected by chance.
Protein Measurements
Microarray results informed our decisions regarding selection of
gene products for measurement at the protein level. A separate
cohort of animals was subjected to the SD protocol and
hippocampi were removed for Western blot analysis on 7 proteins:
ADRB2, Agrin, EAAC1, GluR2, Neurexin 1, NR3B, and SGK-1
(Fig 3). These proteins were chosen because our initial analysis of
microarray data pointed to these neuronal function downregula-
tion or stress response upregulation with SD. Western blot analysis
showed directional agreement for 5/7 products, 4 of which were
significant (Adrb2*, Agrin*, GluR2*, Neurexin 1*, Sgk-1; * sig-
nificant). With the exception of Sgk-1, protein analysis was focused
on neuronal products and appeared to agree with generalized
downregulation seen at the mRNA level. We interpret this as fairly
strong agreement especially considering that the experiment was
done in a separate cohort of animals.
SD Gene List Consolidation
To streamline comparison with other gene expression data,
each ANOVA-significant SD gene’s expression pattern was
Figure 2. Expression patterns for significant genes are shown. Left: Artificially constructed templates (A. Sustained; B. Transient; C.
Delayed, and D. Linear) were used to partition genes into specified patterns. The treatment group mean expression value for each significant
gene was correlated with each of the four templates and the gene was assigned to the template with the highest |R|. Positive correlations are
considered ‘increased’ with SD, negative correlations are considered ‘decreased’. Center: Heatmap for 10 representative genes assigned to each
template and direction are shown. Data are expressed in standardized units and color coded (lower, color scale) by standard deviations from the
mean. Right: Averaged results for all genes in each template are graphed (positive = solid green; negative = dashed orange; # genes in each
pattern reported). Note: error bars plotted but obscured by symbols.
doi:10.1371/journal.pone.0040128.g002
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assigned ‘up’- or ‘down’-regulated status based on the sign of its
correlation. Here, 290 SD genes were upregulated and 370 were
down-regulated.
Pathways Altered in Sleep Deprived Subjects
To identify pathways altered in sleep deprivation, we took the
two largest cohorts of significant genes, the sustained and transient
patterns, and separated them by direction of change. Each
subgroup was uploaded to the DAVID website (Methods) and
subjected to overrepresentation analysis. The delayed and linear
patterns contained significantly more genes than expected by
chance, but had too few genes for DAVID analysis. Therefore
results from these templates were considered individually (Table 1).
A sustained increase glucocorticoid stimulus, a transient decrease
in cell morphogenesis/neurogenesis, and a sustained decrease in
neuronal/synaptic signaling were identified. These results are
largely consistent with prior work on SD and interpretations are
presented in Discussion.
Contrasting Sleep Deprivation and Stress Effects
The SD protocol used here has been shown to elicit a stress
response [27]. To help define sleep vs. stress-related changes, we
performed a third experiment in which subjects were exposed to
novel environment stress (NES) for 24 or 72 hours. This study was
done in parallel with, and shares the same home cage (HC)
controls as, cohort 1 of the SD study. The microarray analysis
process was highly similar to that used for SD analysis (not shown).
Significant results (405 genes, p#0.05, FDR = 0.18, 1-way
ANOVA) were contrasted with results from the SD analysis
(Fig. 4A). The number of genes commonly regulated by the two
experimental conditions was highly unlikely to have occurred by
chance.
NES elicited a smaller transcriptional response than SD.
However, the NES analysis had fewer arrays (N = 21) than SD
(N = 53), likely resulting in reduced statistical discovery power. To
determine whether this difference in N could explain the reduction
in number of significant genes, we performed a resampling analysis
in which the SD study was artificially restricted to only 21
observations. Among the 53 SD chips, a subset of 21 was tested,
and the number of significant genes (1-way ANOVA; p#0.05)
noted. This process was repeated 1000 times with different
randomly selected subsets of 21 chips, generating 1000 estimates of
the number of significant genes expected if the SD study had only
21 chips. These estimates were plotted as a frequency histogram
(Fig. 4B) and were well fit by a Gaussian distribution. The peak of
this distribution (,476) represents the average number of
significant genes we predict would be significant if N = 21 in
the SD study. Superimposing the number of genes actually found
Figure 3. Based on results from microarray analysis, the protein products of 7 genes were analyzed. Western blot analysis was
performed on a separate cohort of sleep deprived and control subjects (n = 12–16/group; HC, 24SD, and 72 SD). Adrenergic beta 2 receptor (Adrb2),
agrin (Agrn), AMPA-selective glutamate receptor 2 (GluR2/Gria2), and neurexin 1 (Nrxn1) were significantly downregulated at both the protein and
mRNA levels. Excitatory amino acid transporter (EAAC1/Slc1a1) and serum glucocorticoid kinase 1 (Sgk/Sgk-1) were not significant at the protein
level. Representative immunoblots from Western analysis are shown for each gene product. Last Panel: Plot of effect sizes (differences in mean
expression expressed in standard deviations) for selected mRNA (microarray) and protein (Western) results for individual gene products shows
general agreement in direction and significance of change.
doi:10.1371/journal.pone.0040128.g003
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significant in the NES study (405 genes- gray area, Fig. 4B)
revealed that the ‘transcriptional magnitude of effect’, between
NES and SD was not significantly different. That is, although 405
NES genes (observed) is less than 476 (predicted) SD genes, it is
not significantly less. Therefore, the high degree of overlap among
genes changed in NES and SD, the agreement in direction of that
change, and, when compensating for statistical power differences,
the relative similarity in the transcriptional strength of these
experimental manipulations all suggest that the functional
processes associated with SD and NES should be highly similar.
To test this, each region of the Venn diagram (Fig. 4A) was
separated by direction of change and analyzed by functional
overrepresentation. We tested the prediction that the two treatments
(SD and NES) would show relatively similar functional grouping
results and that, if anything, SD would show a more refined dissection
of functional groups identified in both SD and NES due to their
similarity at the overlap level. Surprisingly, only the upregulated
immune and apoptosis pathways supported this hypothesis. SD
showed significant and opposite influences on a separate cohort of
immune-related genes, and exclusive upregulation of machinery
Table 1. Pathways influenced by sleep deprivation.
Sustained
Increased Decreased
51384: response to glucocorticoid stimulus (# 8, p = 0.0083) Bad, Ghr,
Hmgb1, Il6r, Plat, Ptgs2, Sgk, Sult1a1
45202: synapse (# 23, p = 0.016) Add1, Chrna7, Cplx1, Dlg2, Erbb3, Gabra3,
Gad2, Gpr51, Grm7, Htr3a, Myh9, P2rx4, Prkar1a, Rabac1, Rgs19ip1, Sdfr1, Slc2a3,
Snca, Sparcl1, Syngr1, Synpo, Syt3, Unc13h1
32355: response to estradiol stimulus (#6, p = 0.023) Bad, Cryab, Gpx1,
Insig1, Ptgs2, Ptk2
06538: glutamate catabolic process (# 3, p = 0.029) Gad2, Glud1, Got2
00165: MAPKKK cascade (# 7, p = 0.024) Cryab, Dusp6, Ghr, Grm4, Mapk14,
Ptk2, Raf1
12506: vesicle membrane (# 9, p = 0.04) Ap2b1, Camk2g, Cftr, Gad2,
Rgs19ip1, Slc2a3, Snca, Syngr1, Tmp21
30198: extracellular matrix organization (#5, p = 0.037) Apex1, Col11a1,
Fn16974, Gadd45a, Hmgb1, Hmgb2, Mapk14, Msh2, P4ha1, Ptk2, Serpinh1, Sgk
43565: sequence-specific DNA binding (#9, p = 0.039) Cebpb, Cutl1,
Hnrpab, Msh2, Neurod1, Nsep1, Pou3f1, Sox10, Znf148
48869: cellular developmental process (#29, p = 0.04) Actb, C1s, Cap1,
Cebpb, Celsr3, Clcn2, Col11a1, Cr16, Cutl1, Dusp6, Fn1, Gpx1, Grm4, Hes1, Hmgb1,
Hmgb2, Hnrpab, Homer1, Ifrd1, Mapk14, Msh2, Myt1l, Neurod1, Pou3f1, Ptk2, Rbp4,
Sgk, Slc1a3, Sox
00902: cell morphogenesis (#11, p = 0.047) Actb, Cap1, Celsr3, Fn1, Hes1, Hmgb1,
Hnrpab, Mapk14, Ptk2, Sgk, Slc1a3
44260: cellular macromolecule metabolic process (#43, p = 0.048)
Apex1, Ccnl, Cebpb, Col11a1, Cryab, Cutl1, Dusp6, Fn1, Galnt1, Ghr, Gpx1, Grm4, Hes1,
Hmgb1, Hmgb2, hnRNPA3, Hnrpa1, Hnrpu, Klf9, Mapk14, Mrpl23, Msh2, Myt1l, Neurod1,
Nfia, Nsep1, P4ha1, Per2, Pou3f1, Ppig, Prkcl1, Psma2, PSMD1, Ptk2, Raf1, Rod1, Rpl10,
Safb, Sgk, Sox10, Top1, Znf148, Znf265
Transient
50790: regulation of catalytic activity (#21, p = 0.0058) Akt2, Arg2, Atpi,
Cd24, Cycs, Eif2ak3, F3, Fkbp1a, Frap1, Grm1, Hsp60, Hspa5, Mapk8ip, Plcd1,
Psma7, Psmd4, Pthlh, Rb1, Rbl2, Ssbp1, Vldlr
22803: passive transmembrane transporter activity (# 12, p = 0.014)
Cacna1g, Cacnb3, Chrnb4, Gjb1, Grik5, Grin2d, Kcnj14, LOC293497, Mip, Scn1b,
Snap25, Z49858
43255: regulation of carbohydrate biosynthetic process (#4, p = 0.013)
Akt2, Frap1, Plcd1, Ppp1cb
06970: response to osmotic stress (# 5, p = 0.018) Avp, Avpr1, Bax, Kmo,
Sord
04435: phosphoinositide phospholipase C activity (#3, p = 0.025)
Plcb1, Plcd1, LOC84587
42175: nuclear envelope-endoplasmic reticulum network (#8, p
= 0.018) Bax, Cyp2e1, Fdft1, Gjb1, Oprs1, Pemt, Psen1, Sqle
06919: activation of caspase activity (#4, p = 0.027) Cycs, F3,
Eif2ak3, Hsp60
44431: Golgi apparatus part (#10, p = 0.035) Cspg5, Cyp2e1, Loc192276,
LOC246768, Pcsk7, Siat1, Siat8b, Snap25, Sod3, Vamp2
05509: calcium ion binding (#15, p = 0.037) Cdh8, Chga, Grp94, Itpr1,
LOC84587, Lre3, P5, Plcb1, Plcd1, Pthlh, Pva, Ret, Tpt1, Trrp1, Vldlr
48667: cell morphogenesis involved in neuron differentiation (#9, p
= 0.041) Cdk5r, Cnp1, Cspg5, Ephb1, Fez1, Ncaml1, Snap25, Spr, Unc5h2
10468: regulation of gene expression (#24, p = 0.038) Akt2, Cdc5l, Cited2,
Csda, Dbp, Eif2ak3, Eif4g2, Frap1, Gtf2a2, Hivep1, Hivep2, Hsf1, Hsp60, Litaf,
LOC81816, Mapk8ip, Nr1d2, Pax6, Pou3f3, Pthlh, Rb1, Rbl2, Roaz, Znf146
19222: regulation of metabolic process (#36, p = 0.045) Akt2, Arg2, Atpi,
Cd24, Cdc5l, Cited2, Csda, Dbp, Eif2ak3, Eif4g2, Epac, Fkbp1a, Frap1, Grm1, Gtf2a2,
Hivep1, Hivep2, Hsf1, Hsp60, Litaf, LOC81816, Mapk8ip, Nr1d2, Pax6, Pdgfra, Plcd1,
Pou3f3, Ppp1cb, Psma7, Psmd4, Pthlh, Rb1, Rbl2, Roaz, Vldlr, Znf146
34645: cellular macromolecule biosynthetic process (#22, p = 0.05)
Cdc5l, Csda, Dbp, Eif2ak3, Eif5, Gtf2a2, Gyg, Hivep2, Litaf, Nr1d2, Pax6, Rb1, Rbl2, Roaz,
Rpl14, Rpl17, Rpl21, Rpl32, Rps15a, Slipr, Ssbp1, Znf146
Genes with sustained or transient expression patterns (Fig. 2A, B) were separated by direction and analyzed by functional grouping overrepresentation analysis
(Methods). Representative categories for each pattern and direction are listed with Gene Ontology ID and description. The number of significant genes (#) and DAVID
modified Fisher exact score p-value are given in parentheses, followed by alphabetical listing of gene symbols within each pathway.
doi:10.1371/journal.pone.0040128.t001
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involved in mRNA translation to protein, and downregulation of
neuronal components (illustrated in Fig. 4C).
Comparison to other SD Studies
The overlap analysis approach used for the following compar-
isons has a strong tendency to increase confidence in true positive
findings at the expense of false negatives [40]. It is also important
to note that differences across laboratories, SD techniques, brain
regions studied and species used likely account for disagreements
among studies. Thus, genes identified in multiple studies should
represent robust SD responses that are less likely to be species
and/or brain region-dependent.
Complete microarray datasets are available for two mouse brain
studies of sleep deprivation: GSE 6514 [53]; GSE 23628 [54].
Downloaded and compared to our data set, 495 total genes were
present in all three studies. Significant genes: our study = 169,
Mackiewicz = 148, and Thompson = 63. By chance, 1 gene
should be found significantly changed in the same direction by all
three studies, while 4 were observed to change (p = 0.024,
binomial test). Downregulated in all three studies: Cirbp (cold-
inducible binding protein), S100a1 (S100 calcium binding protein
A1) and Ednrb (endothelin receptor type 1). Interestingly, the
three downregulated genes were also robustly downregulated in
our NES group.
Three studies examined SD-related transcriptional changes in
rat hippocampus [50], rat cerebral cortex [55], or mouse forebrain
[56]. However, lists of selected significant genes, rather than
complete data sets, are available for these studies. Thus, we
restricted reports to genes found within our filtered data set, and
used a statistical approach similar to that employed in DAVID
analysis (679/2167 = 35% of our data set significant; selected
genes then, 17.5% chance of significance and directional
Figure 4. Novel environment stress (NES) elicited a transcriptional response highly similar to that seen with SD. A separate cohort of
animals exposed to NES were subjected to hippocampal microarray analysis. Of the 2167 filtered genes, 405 were identified as significant in the stress
study (p#0.05; 1-way ANOVA; FDR = 0.18). A. Venn diagram comparing stress (black circle) and SD (SD- white circle) array results reveals a highly
significant overlap of 189 genes significant in both studies (* p = 1.5561028; binomial test). Directional analysis revealed that 96% (182/189; 81
upregulated; 101 downregulated) of these overlapping genes agreed in direction of change. B. NES was powered by 21 microarrays, while SD was
powered by 53. Because of this discrepancy, the greater number of genes found in SD could reflect increased discovery power, rather than a stronger
effect of SD. To test this, we iteratively selected subsets of 21 arrays from the 53 used in the SD study and tested for significance. This was repeated
1000 times and in each iteration, the number of genes significant (p#0.05, 1-way ANOVA) were counted. The results from all 1000 iterations are
plotted as a frequency histogram (open circles). This was well-fit by a Gaussian function (heavy black line, p,0.0001, R2 = 0.91) with a peak of 476.4-
meaning that, on average if only 21 chips had been used in the SD study, we would predict that 476 genes would be found significant. Using the fit
function, and the observation that 405 genes were found in the NES study, we fail to support the hypothesis that SD finds more genes than NES (p
= 0.24; integrated area under the curve- gray). C. Gene Ontology Analysis for genes in each region/direction of change within the Venn diagram.
doi:10.1371/journal.pone.0040128.g004
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agreement across studies). Conti et al report 15 significant genes, 7
of which were significant and changed in the same direction in our
study. Mongrain et al report 141 significant results (exclusively
among control vs. sleep deprived intact animals). Fifty of these are
significant and agree in direction in the present work. Cirelli et al
report 28 genes, 12 of which were significant in our study. All of
these comparisons were significant (p#0.05; binomial test) and
Table 1 is annotated with these findings. Interestingly, Homer1
was significantly upregulated in all five prior microarray sleep
deprivation studies, as well as in our own study, and was not
significantly influenced by NES.
Comparison to Hippocampal Aging
We tested the prediction that SD would cause an aging-like shift
in hippocampal gene expression by assembling a composite set of
aging genes in rat hippocampus based on three studies [31,32,33].
The simplified ‘aging union’ results (up- or downregulated in at
least one of the prior aging studies- see Methods) are annotated in
Table S1. 617 genes changed with aging and 670 changed with
SD. Functional overrepresentation analysis (see Methods) was
possible (Fig. 5C) for genes uniquely regulated by SD (456 genes)
or Aging (403 genes). Aging showed a selective upregulation of
pathways related to transcription, lipid metabolism, and Ca2+
signaling. Further, downregulated categories were almost exclu-
sively related to neuronal function. Interestingly, sleep deprivation
appeared to also downregulate a strong, but different, cohort of
neuronal genes (Fig. 5C lower right), suggesting that SD and aging
may have additive influences on brain function. Upregulated
exclusive SD genes included processes related to protein handling
and degradation, as well as well-characterized upregulation of
stress hormone stimulus pathways.
A significant subset (214 genes, p = 0.028, binomial test; Fig. 5A)
are changed by both SD and aging. Therefore, as with the
comparison between SD and NES (Fig. 4), aging and SD appear to
exert influence over a common set of genes. However, unlike the
very strong tendency for SD and NES gene expression to agree in
direction (Fig. 4A), this could not be said of aging and SD (Fig. 5A,
lower), where significant genes were split- 128/214 agreed in
direction. We partitioned the overlapping 214 genes into four
quadrants based on direction of change in aging and SD. Because
the resulting profiles were too small for reliable DAVID functional
grouping statistical analysis, genes were manually categorized
(Fig. 5B- and see below). Immune/inflammatory, neuronal, and
macromolecular synthesis categories showed the largest effects.
Division/differentiation/apoptosis, energy metabolism, protec-
tion/antioxidant, and transcription factor changes appeared
similar in aging and SD. Glial changes were upregulated in aging,
and a subset of those upregulated changes moved in the opposite
direction with SD. Finally, glucocorticoid sensitivity and circadi-
an/sleep were both downregulated with age and upregulated by
SD. Individual genes listed in each condition or category, along
with notes regarding putative function, are included below.
1) Upregulated in both aging and SD (60
genes). Division/differentiation/apoptosis: Ap1b1, Cd24, Cdc5l,
Msh2, Vcp
Energy/metabolism: Aldoc, Ech1, Gatm, Sds, Slc2a1
Glial: Adk, Cryab, Ocln, Mt1a, Oplah, Pmp22 (although exclusively
expressed in peripheral nervous system, mRNA is detected in
CNS, see Allen Brain Atlas- [57]), Slc1a3
Immune/inflammatory: C1qb, Cyp4f4, Fn1*, Hmgb2, Ndrg2,
Ptgs1* (* inflammatory)
Macromolecular synthesis: Csda*, Eif4ebp1*, Eif5, Rpl10, Rpl21,
Rpl23, Rps15, Rps21, Rps5, Rps7 (* suppresses synthesis)
Neuronal: Adra1d, Fxyd1, Gng5, Grip2, Ptpn1, Ralgds, Slc1a3,
Sult1a1
Protection/antioxidant: Cited2, Gpx1, Prdx6, Sepp1, Sod3, *Xdh
(*pro-oxidation)
Transcription factor: Dbp, Neurod1, Nfia
2) Downregulated in both aging and SD (64
genes). Division/differentiation/apoptosis: Egr1, Igf2, Lxn, Met,
Ngfrap1, Sc65
Energy/metabolism: Acat1, Atp9a, Amacr, Atp1a3, Dnm1l, Fez1,
Got2, Ivd, Tst
Immune/inflammatory: Add1, Ap3m2, Csrp2, Cx3cl1, Dcn, Dpp3,
Ide, Lamc1, Lrpap1, Muc1, Tubb5 (primarily fibril formation and
inflammation-related genes)
Macromolecular synthesis: Cyp51, Faah, Fapb3, Hmgcr*, Sqle* (*
rate-limiting enzymes in the sterol biosynthesis pathway)
Neuronal: Accn1, Adcy5, Agrn, Ap2b1, App, Calb1, Calb2, Capns1,
Crmp1, Fez1, Gabbr1, Gda, Htr2c, Kcns3, Nnat, Pctk1, Pkia, Por,
Ppp2r2c, Prkar1a, Ptpra, Ptprn2, Rab12, Slc1a1, Snca, Syt4
3) Upregulated in aging and downregulated by SD (46
genes). Glial: Fgfr2, Gfap, Gjb1, Rab13, Tip2
Immune/inflammatory: Dbnl, Grn*, Lamp1*, Litaf*, Plat*, Psme1
(* inflammatory)
Macromolecular synthesis: Gpam, Insig1, Magat1, Pgr, Phgdh,
Ppap2c, Rpl29, Srebf1
Neuronal: Akr7a2, Bin1, Cpd, Cplx2, Klk6, Nln, Pgr, Pla2g2c,
Syngr1, Vamp1
4) Downregulated in aging and upregulated by SD (44
genes). Neuronal: Apbb3, Begain, Calr, Celsr3, Cgref1, Chga, Hspa4,
Ifrd1, Marcks, Mark3, Npy, Rgs14, Tac1, Vgf (Note: Tac1, Ifrd1, and
Npy may also be related to immune or inflammatory signaling)
Immune/inflammatory: Arg2, Col11a1, Serpinh1, Tpm1 (generally
opposes other inflammatory signals)
Glucocorticoid sensitivity: Chrbp1, Fkbp4 (expression opposes
glucocorticoid action)
Circadian/sleep: Homer1, Per2
Discussion
We used a modified ‘flower pot’ method to provide sustained
Sleep Deprivation (SD) [28,58] and included a novel environment
stress (NES) control in order to separate the effects of SD from
those of NES on hippocampal gene expression. Transcriptional
profiling of the hippocampal CA1 brain region was selected
because the hippocampus is well-understood to be negatively
affected by SD, aging, and stress. We also tested whether SD
would elicit aging-like changes in the transcriptional profile.
Significant overlapping gene expression profiles were observed for
SD and stress, but much less so for SD and aging. Our studies of
the transcriptional effects of SD also identified candidate
druggable targets for the development of new sleep countermea-
sures. In addition to supporting a role for certain genes in sleep
modulation (e.g., Homer1), our studies identified some novel
pathways as potential targets for intervention in SD, most notably
those involved in synaptic function.
SD has stress-like components. In agreement with prior
studies, body weight loss and corticosterone elevation (Fig. 1A,C)
suggest that animals perceived the SD environment as a stressor
[59]. Animals exposed to novel environment stress (NES) had a
strong directional agreement with SD (Fig. 4) for ,1/3 of all
significant SD genes. Based on that overlap, and on the relatively
smaller effect of NES, we hypothesized that NES subjects
experienced a similar but lower intensity combination of stress
and sleep loss compared to SD subjects. To test this, we
controlled for the lower statistical power of the NES study
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(Fig. 4B), and found that the transcriptional magnitude of effect
was not significantly different in SD and NES. Therefore, it
appears that the NES animals manifested a transcriptional
response similar to that of SD. However, selective SD pathways
not found in NES (energy metabolism, macromolecular synthesis,
and neuronal function) support some of the most prominent
mechanistic hypotheses of sleep function in brain tissue [20,60].
Thus, SD appeared to exert a composite effect [30,61] on the
hippocampal transcriptome consistent with both stress and sleep’s
hypothesized function(s). Elegant work depriving certain sleep
stages without enriching wake [62], or invoking SD and its
concomitant stressors in the absence of stress-related hormone
secretion [56] likely will help to elucidate the separate
contributions of these phenomena.
Protein Measures/Validation
We also tested the hypothesis that mRNA level changes
identified by microarray translate to protein using a separate
cohort of similarly sleep-deprived animals. Western blots for
Adrb2, Agrin, Gria2, and Neurexin support this. Although Sgk1
and Slc1a1 failed to reach significance in the protein measures,
they showed the same direction of change and it may be
unreasonable to expect complete agreement using overlap
comparisons. The overall finding of 4 genes agreeing, and two
more agreeing in direction of change, particularly in a separate set
of subjects measuring a different type of molecule, appears to
constitute reasonable corroboration. Additionally, prior micro-
array SD studies in brain tissue [50,54,56,60] also validate these
findings (noted in Table S1; see [63] for discussion on limitations
of this approach).
Figure 5. SD and aging influence a similar set of genes. A. Unlike NES (Fig. 4), the significant overlap between aging and SD (* p = 0.028,
binomial test) contained many genes whose change with age was opposite to that in SD. B. 158/214 genes in the overlap were manually assigned to
one of 10 heuristic categories. Because of this approach, no statistical overrepresentation p-values are possible. The number of genes from within
each quadrant of the overlap (agreed with SD, aging up, aging down; disagreed in SD- aging up, aging down) are shown. Genes in each category are
listed in Results. C. Functional categorization genes regulated exclusively by Aging (upper) or Sleep Deprivation (lower) are separated based on
direction of change (Left: Upregulated; Right: Downregulated).
doi:10.1371/journal.pone.0040128.g005
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Relationship to Aging
Prior studies have shown that sleep depriving young subjects
can result in aging-like behavioral and metabolic changes [62].
Further, in humans and animal models, sleep loss appears to be a
normal consequence of the aging process, and could be a
proximate cause of age-related functional deficits [64]. We
predicted that artificially restricting sleep in young animals would
evoke an aging-like transcriptional profile. We constructed a
unified aging profile based on three different rat hippocampal
studies. At an initial level, our hypothesis was supported as we
found a highly significant subset of genes influenced by both SD
and aging (Fig. 5). Surprisingly, many genes significant in both SD
and aging changed in opposite directions, suggesting a more
complex relationship.
Overall, a significantly greater number of genes than expected
by chance were regulated by both aging and sleep deprivation
(Fig. 5). However, contrary to our hypothesis, genes within this
‘aging and SD transcriptional window’ were not generally moved
in the same direction by the two phenomena. Although our
prediction’s first component (i.e., that more genes than expected
by chance would be influenced) was supported, the second
component (that those overlapping genes would be similarly
influenced by the two phenomena), was not. This suggests that
age-related changes interact in a more complex manner with SD-
related genes. A build-up of Homer1 expression with increasing
sleep deprivation seen here has been reported in other work
[50,54,55,56,65,66,67]. Conversely, multiple studies have shown a
decrease in Homer1 expression, with aging [31,32,33,68] suggest-
ing that Homer1, and possibly other candidate sleep-pressure
signaling systems, may serve as a lynch pin for discrepancies
between young and aged sleep behavior and molecular profiles.
Interestingly, with the exception of Homer 1 and Synaptogyrin 1,
analysis focused on synapse-related gene expression (Fig. 6) points
to aging’s similarity to SD’s influence (moves Add1, Agrin, App,
Grip2, Slc1a1, Slc1a3, Synaptogagmin 4, GABAB, and the
Adrenergic a1 receptor in the same direction as SD). Future
studies examining the influence of stress, stress hormone, and their
interaction with sleep and Homer1 expression with age may help
to further clarify these issues.
Overlapping genes were categorized by direction of change in
aging and SD, as well as by putative function (Fig. 5B). Processes
that changed with aging and were apparently recapitulated with
SD included cell differentiation/apoptosis, energy, antioxidant
and transcription factor activity. Among genes that disagreed
between aging and SD, two that influence sensitivity to
glucocorticoid, Chrbp and Fkbp4 (also upregulated in a prior
SD study- [56]), were upregulated in SD and downregulated with
age in the present analysis. Changes in the expression of these
candidate molecules may dampen glucocorticoid’s influence on
immune/inflammatory and glial activity with age [25]. Intriguing
parallels to work on other steroid hormones [69], suggest that, with
age, the brain may shift its response to glucocorticoids. Whether
such mechanisms may involve nuclear or non-nuclear receptor
pathways [70] remains to be determined.
Two sleep-related genes, Per2 and Homer1, were suppressed
with age but upregulated with SD. Per2 is a circadian clock gene
upregulated in prior SD studies [56] as well as in our NES
treatment group, suggesting it may not be a purely SD-related
finding. Homer1 was among the few genes that showed a linear
increase with extended SD and was not influenced by NES.
Further, multiple SD studies have also reported Homer1
upregulation with SD [50,54,55,56,66]. Homer1 may play an
important role in sleep pressure signaling [65,66,67,71]. Because
the brain exhibits less deep-sleep with age in both humans [64,72]
and animal models [73,74,75,76,77,78], we speculate that
Homer1’s consistent downregulation with aging [31,32,33] could
constitute a broken molecular switch leading to a loss of deep sleep
with age.
Therapeutic Targets for Intervention in SD
Results point to a focused effect on mRNA associated with
synaptic function. We constructed an idealized hippocampal
glutamatergic synapse (Fig. 6), and superimposed SD profile results
(the calcium-sensing protein S100A1 is included because it co-
localizes with synapsin in brain tissue [79]). Gene products were
identified using literature and ontology database searches: 46 were
significantly altered by sleep deprivation- the majority downreg-
ulated. Results suggest SD-induced synaptic efficacy and macro-
molecular synthesis changes, consistent with previous work
[22,60].
In keeping with the proposed mechanisms of action for current
SD countermeasures (e.g., caffeine, amphetamine, modafinil, the
ampakine CX717), there appears to be a deficit in glutamatergic
signaling with SD. Interestingly, Chga (chromogranin A) upregula-
tion has been reported to suppress presynaptic vesicular release
components [80,81] and may, at least in part, play an upstream
role in mRNA expression changes associated with the pre-synapse.
This may help to explain how SD-countering drugs [82] can exert
their effects and highlights the potential clinical importance of
astrocytic [83], orexinergic and adrenergic systems. Results also
suggest that drugs facilitating Ca2+-dependent vesicular release
(one of caffeine’s proposed mechanisms of action), neurotransmit-
ter re-uptake block (one of amphetamine’s proposed mechanisms
of action) may counter SD’s effects. Among newer agents, the
ampakine CX717 is proposed to exert its wake-promoting effects
via enhanced glutamatergic signaling [82,84]. Conversely, drugs
that constrain neuronal activity via: reduced sustained high
frequency repetitive discharge (e.g, phenytoin); enhanced inhibi-
tory surround (e.g., phenobarbital); or disrupted vesicular release
(e.g., levetiracetam) facilitate sleep [85]. The development of drugs
that enhance presynaptic release, a mechanism of action relatively
unexplored by current wake-promoting agents, seems a valid
target for the development of future sleep countermeasures.
No currently available sleep countermeasures allow human
‘normal wake’ performance over extended (three or more days)
periods of time. Frank limitations include dissociative/psychotic
behavior after prolonged exposure, risk of developing tolerance/
dependence on the agents being used, and lowered seizure
thresholds [86]. Our microarray results indicate that synaptic
function-related mRNA expression changes do not occur in a
vacuum. Among other categories of change, the reduction in
intercellular adhesion molecule expression may be of particular
importance. These molecules are pleiotropic and in addition to
playing a role in inflammation and immune signaling, also help
maintain synaptic juxtaposition. We speculate that their down-
regulation in SD could leading to aberrant synaptic signaling.
Thus, the development of drugs targeting the stabilization of
intercellular adhesion molecules may help to extend the duration
of action for stimulant-based sleep countering agents.1.
Summary. Our findings support long-standing observations
that SD elicits physiologic and transcriptional responses with
stress-like features. Neuronal synaptic gene expression changes
may help to explain the benefits and limitations of current
stimulant-based SD-countering therapeutics and points to novel
targets in presynaptic vesicular release and neural cell adhesion for
development of future SD-countering drugs. Significantly more
genes than expected by chance were commonly regulated by both
aging and SD. Although many were driven in the same direction
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by these two phenomena, we could not fully support the
hypothesis that SD evokes an aging-like transcriptional change.
Genes showing significant but opposite expression changes in SD
and aging, including Chrbp, Fkbp4, Homer1 and Per2, are candidates
for further study of the interplay between SD and aging.
Compared to prior studies showing increased inflammatory
signaling with stress, our novel environment stress (NES) protocol
did not influence inflammatory gene expression to an appreciable
extent, and SD suppressed those signals. This suggests that SD in
our hands was either a weak stressor, or that it has an effect
mechanistically distinct from that of stress on immune signaling.
Supporting Information
Table S1 Genes whose expression levels were signifi-
cantly changed as a consequence of sleep deprivation
are listed. Probe set IDs (Affymetrix), annotated gene symbols
(hyperlinked to Uniprot), and gene titles are shown. Subsequent
columns contain comparisons to other array studies as noted in
Methods and Results (blank if no results were found). Both
significance, as well as template (see Fig. 2) with which results best
fit are provided for novel environment stress (NES), as well as sleep
deprivation (SD). For SD, means 6 SEM for each treatment
group are also provided.
(XLSX)
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